| Literature DB >> 31067497 |
Rajendra Raghow1, Qingming Dong2, Marshall B Elam2.
Abstract
Lipid homeostasis is critically dependent on the liver. Hepatic genes involved in lipid biosynthesis are controlled by combinatorial actions of multiple transcription factors that include three sterol regulatory element binding proteins (SREBPs), carbohydrate responsive element binding protein, liver X receptors, and others. SREBP-1c, a seminal regulator of de novo lipogenesis, resides in the endoplasmic reticulum as a transcriptionally inert precursor and must undergo a regulated intramembrane proteolysis (RIP) prior to its nuclear translocation as a bone fide transcription factor. The regulation of biosynthesis, turnover and actions of SREBP-1c and lipogenesis are mechanistically linked to signaling kinases, canonically induced by macronutrients and insulin. Here, we briefly review the evidence showing that phosphorylation of SREBP-1c and its interacting partners, catalyzed by phosphatidyl inositol-3-kinase, protein kinase B, mechanistic target of rapamycin complex 1 and 2, mitogen activated protein kinases, glycogen synthase kinase-3β, protein kinase A and 5' adenosine monophosphate-activated protein kinase regulates the mechanisms of RIP and stability of SREBP-1c and de novo lipogenesis. Published by Elsevier B.V.Entities:
Keywords: De novo lipid synthesis; Metabolic syndrome; Phosphorylation; Regulated intramembrane proteolysis; Sterol regulatory element binding proteins; Type-2 diabetes
Mesh:
Substances:
Year: 2019 PMID: 31067497 DOI: 10.1016/j.bbalip.2019.04.015
Source DB: PubMed Journal: Biochim Biophys Acta Mol Cell Biol Lipids ISSN: 1388-1981 Impact factor: 4.698